Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells.
暂无分享,去创建一个
J. Charrow | A. Rosenberg | A. Amalfitano | P. Kishnani | J. Mackey | S. Banugaria | Trusha Patel | Y-T. Chen | Stuti Das | Y.-T. Chen